| Literature DB >> 34309006 |
Paola Vassallo1, Jan Novy1, Frédéric Zubler2, Kaspar Schindler2, Vincent Alvarez1,3, Stephan Rüegg4, Andrea O Rossetti1.
Abstract
OBJECTIVES: Occurrence of EEG spindles has been recently associated with favorable outcome in ICU patients. Available data mostly rely on relatively small patients' samples, particular etiologies, and limited variables ascertainment. We aimed to expand previous findings on a larger dataset, to identify clinical and EEG patterns correlated with spindle occurrence, and explore its prognostic implications.Entities:
Keywords: coma; critical care; outcome; spindles
Mesh:
Year: 2021 PMID: 34309006 PMCID: PMC9290497 DOI: 10.1111/ane.13510
Source DB: PubMed Journal: Acta Neurol Scand ISSN: 0001-6314 Impact factor: 3.915
Patients characteristics: all participants (n= 364).
| Present spindles | Absent spindles | p | test | |
|---|---|---|---|---|
|
| 83 (22.8%) | 281 (77.2%) | ||
|
| 63.8 (±15.9) | 63.8 (±14.6) | 0.983 | t |
|
| 30 (36.1%) | 93 (33.1%) | 0.606 | χ2 |
|
| 66 (79.5%) | 221 (78.7%) | 0.865 | χ2 |
|
|
0.581 |
Fisher | ||
| Primary brain injury | 40 (57.1%) | 151 (63.5%) | ||
| Medical | 19 (27.1%) | 57 (24.0%) | ||
| Surgical | 10(14.3%) | 23 (9.7%) | ||
| Other | 1 (1.4%) | 7 (2.9%) | ||
|
|
0.805 |
χ2 | ||
| anoxic‐ischemic | 20 (24.1%) | 92 (32.7%) | ||
| brain trauma | 11 (13.1%) | 37 (13.2%) | ||
| intracranial hemorrhage | 19 (22.9%) | 66 (23.5%) | ||
| ischemic stroke | 8 (9.6%) | 20 (7.1%) | ||
| toxic‐metabolic | 6 (7.2%) | 17 (6.0%) | ||
| other | 19 (22.9%) | 59 (21.0%) | ||
|
| 45.7 (±18.6) | 49.8 (±19.0) | 0.123 | t |
|
| 3 (3–7) | 3 (3–6) | 0.082 | U |
|
| 5 (3–8) | 4 (1–7) |
| U |
|
| 63.2 (25.8–150.9) | 57.5 (22.3–135.7) | 0.341 | U |
|
| 61 (73.5%) | 121 (43.1%) |
| χ2 |
|
| 25 (30.1%) | 98 (34.9%) | 0.421 | χ2 |
|
| 44 (53.0%) | 146 (50.9%) | 0.866 | χ2 |
|
| 40 (48.2%) | 154 (54.8%) | 0.289 | χ2 |
| dose, mg/kg/h (median, IQR) | 0.94 (0.18–1.92) | 0.87 (0.16–1.87) | 0.823 | U |
|
| 34 (41.0%) | 113 (40.2%) | 0.903 | χ2 |
| dose, mg/kg/h (median, IQR) | 0.09 (0.03–1.17) | 0.08 (0.01–1.19) | 0.920 | U |
|
|
|
χ2 | ||
| continuous | 75 (90.4%) | 208 (74.0%) | ||
| discontinuous | 7 (8.4%) | 32 (11.4%) | ||
| burst‐suppressed | 1 (1.2%) | 24 (8.5%) | ||
| suppressed | 0 | 17 (6.1%) | ||
|
|
0.086 |
Fisher | ||
| alpha or beta | 32 (38.6%) | 78 (27.8%) | ||
| theta | 50 (60.2%) | 185 (65.8%) | ||
| delta | 1 (1.2%) | 7 (2.5%) | ||
| none | 0 | 11 (3.9%) | ||
|
| 81 (97.6%) | 227 (80.8%) |
| χ2 |
|
| 24 (28.9%) | 58 (20.6%) | 0.113 | χ2 |
|
| 17 (20.4%) | 68 (24.2%) | 0.482 | χ2 |
|
| 5(6.0%) | 32 (11.4%) | 0.155 | χ2 |
|
| 38 (45.8%) | 108 (38.4%) | 0.230 | χ2 |
|
| ||||
| Mortality | 33 (39.8%) | 144 (51.3%) | 0.066 | χ2 |
| CPC in survivors (median, IQR) | 2 (1–3) | 2 (1–3) | 0.521 | U |
| ΔmRS in survivors | 1 (0–2) | 1 (0–2.5) | 0.204 | U |
Abbreviations: ASM, Anti‐Seizure Medication; CPC, Cerebral Performance Category; FOUR, Full Outline of UnResponsiveness; GCS, Glasgow Coma Score; GPD, generalized periodic discharges; GRDA, generalized rhythmic delta activity; IQR, interquartile range; LPD, lateralized periodic discharges; LRDA, lateralized rhythmic delta activity; MDZ, midazolam; SAPS, Simplified Acute Physiology Score; SD, standard deviation; ΔmRS, difference of modified Rankin Scale between 6 months and before admission.
Bold values are significant (univariable analyses).
Participants with continuous EEG (182).
| Present spindles | Absent Spindles | p | test | |
|---|---|---|---|---|
|
| 61 (33.5%) | 121 (66.5%) | ||
|
| 63.5 (±15.7) | 64.2 (±13.9) | 0.740 | t |
|
| 19 (31.2%) | 43 (35.5%) | 0.555 | χ2 |
|
|
0.128 |
χ2 | ||
| anoxic‐ischemic | 15 (24.6%) | 45 (37.2%) | ||
| brain trauma | 10 (16.4%) | 21 (17.4%) | ||
| intracranial hemorrhage | 15 (24.6%) | 30 (24.8%) | ||
| ischemic stroke | 4 (6.6%) | 6 (5.0%) | ||
| toxic‐metabolic | 2 (3.3%) | 7 (5.8%) | ||
| other | 15 (24.6%) | 12 (9.9%) | ||
|
| 45.4 (±18.5) | 51.5 (±19.0) | 0.057 | t |
|
| 3 (3–7) | 3 (3–6) |
| U |
|
| 5 (3–8) | 3 (1–6) |
| U |
|
|
|
χ2 | ||
| continuous | 54 (88.5%) | 88 (72.7%) | ||
| discontinuous | 7 (11.5%) | 12 (9.9%) | ||
| burst‐suppressed | 0 | 10 (8.3%) | ||
| suppressed | 0 | 11 (9.1%) | ||
|
|
0.103 |
Fisher | ||
| alpha or beta | 24 (39.3%) | 32 (26.4%) | ||
| theta | 36 (59.0%) | 78 (64.5%) | ||
| delta | 1 (1.6%) | 5 (4.1%) | ||
| none | 0 | 6 (5.0%) | ||
|
| 59 (96.7%) | 87 (71.9%) |
| χ2 |
|
| 20 (32.8%) | 33 (27.3%) | 0.440 | χ2 |
|
| 12 (19.7%) | 34 (28.1%) | 0.217 | χ2 |
|
| 5 (8.2%) | 24 (19.8%) |
| χ2 |
|
| 26 (42.6%) | 50 (41.3%) | 0.867 | χ2 |
|
| ||||
| Mortality | 20 (32.8%) | 69 (57.0%) |
| χ2 |
| CPC in survivors (median, IQR) | 2 (1–2) | 2 (1.5–3) | 0.094 | U |
| ΔmRS in survivors | 1 (0–2) | 2 (1–3) |
| U |
Abbreviations: CPC, Cerebral Performance Category; FOUR, Full Outline of UnResponsiveness; GCS, Glasgow Coma Score; GPD, generalized periodic discharges; GRDA, generalized rhythmic delta activity; IQR, interquartile range; LPD, lateralized periodic discharges; LRDA, lateralized rhythmic delta activity; MDZ, midazolam; SAPS, Simplified Acute Physiology Score; SD, standard deviation; ΔmRS, difference of Modified Rankin Scale between 6 months and before admission.
Bold values are significant (univariable analyses).